MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2016 International Congress

    Application and correlates of the PSP quality of life scale

    L.A. Higginbotham, V. Johnson, A. Pantelyat (Baltimore, MD, USA)

    Objective: To apply the PSP Quality of Life scale (PSP-QoL) within a cross-sectional PSP population and correlate these scores with those of the PSP rating…
  • 2016 International Congress

    PROSPECT: A UK-based longitudinal observational study of PSP, CBD, MSA and atypical parkinsonism syndromes

    J. Woodside, R. Lamb, V. Chelban, D. Burn, A. Church, A. Gerhard, M. Hu, N. Leigh, J. Rowe, H. Houlden (London, United Kingdom)

    Objective: To aid the development of curative treatments, we need to develop better methods for diagnosing Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD) and Multiple…
  • 2016 International Congress

    Manual MRI morphometry in Parkinsonian syndromes

    L. Möller, J. Kassubek, M. Südmeyer, R. Hilker, E. Hattingen, K. Egger, F. Amtage, G. Respondek, M. Stamelou, A. Schnitzler, W.H. Oertel, S. Knake, H.J. Huppertz, G.U. Höglinger (Marburg, Germany)

    Objective: We investigated a large sample of Parkinsonian patients and healthy controls from five German academic medical centers with 3D MP-RAGE sequences on mainly 3T…
  • 2016 International Congress

    Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease

    P. Chana-Cuevas, C. Juri, V. Kramer, R. Pruzzo, P. Riss, A. Amaral, F. Rösch, H. Amaral (Santiago, Chile)

    Objective: To evaluate the differences in striatal subregional dopamine transporter loss in Parkinson's disease (PD) and supranuclear palsy (PSP) and the diagnostic value of [18F]PR04.MZ…
  • 2016 International Congress

    Analysis of MAPT, GRN and C9orf72 genes in progressive supranuclear palsy, corticobasal syndrome and frontotemporal lobar degeneration in Russian population

    E.Y. Fedotova, N.Y. Abramycheva, M.S. Stepanova, A.S. Vetchinova, S.N. Illarioshkin (Moscow, Russia)

    Objective: To investigate MAPT variants and haplotypes, GRN mutations, and C9orf72 expansion in a cohort of Russian patients with progressive supranuclear palsy (PSP), cotricobasal syndrome…
  • 2016 International Congress

    Leukocyte perturbations suggest immune dysregulation in progressive supranuclear palsy

    M.C. Schiess, J.O. Suescun, A. Actor, A. Gonzales, K.C. Smith (Houston, TX, USA)

    Objective: Compare the serum cytokine profiles and phenotypes of peripheral blood mononuclear cells (PBMCs) in a patient with Progressive Supranuclear Palsy (PSP) with his healthy…
  • 2016 International Congress

    Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia

    S. Kurcova, K. Mensikova, L. Tuckova, J. Ehrmann, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To report two cases of patients with unusual manifestation of pathologically confirmed PSP. Background: Based on the results of recent multicenter clinical-pathological studies, it…
  • 2016 International Congress

    A pilot study of whole exome sequencing in progressive supranuclear palsy

    K.Y. Mok, A. Tucci, R. de Silva, H.R. Morris, A.B. Singleton, H. Houlden, J. Hardy, IPDGC (London, United Kingdom)

    Objective: To identify genetic variants associated with Progressive Supranuclear Palsy (PSP) using whole exome sequencing. Background: PSP is a rare tauopathy but is the second…
  • 2016 International Congress

    Progressive supranuclear palsy as a manifestation of the second stage of CADASIL syndrome

    B. Muinjonov, E. Giyazitdinova, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: To describe progressive supranuclear palsy (PSP) as a clinical manifestation of second stage CADASIL syndrome. Background: Recent data suggests that CADASIL syndrome in rare…
  • 2016 International Congress

    PSP and HIV: Causality or coincidence?

    L.A. Crespo Araico, P. Agüero Rabes, E. Viedma Guiard, P. Martinez Ulloa, C. Estévez Fraga, A. Alonso Cánovas, I. Corral Corral, L. Cabañes Martinez, E. Navas Elorza, J.C. Martinez Castrillo, I. Avilés Olmos (Madrid, Spain)

    Objective: Our aim was to describe the clinical picture of an HIV patient with a progressive neurodegenerative disorder likely Progressive supranuclear palsy (PSP). Background: Movement…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley